Soleno Therapeutics (SLNO) EBITDA (2013 - 2026)
Soleno Therapeutics (SLNO) reported EBITDA of $29.1 million for Q1 2026, up 166.33% year-over-year from $10.9 million in Q1 2025, and down 32.91% on a QoQ basis from $43.4 million in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of EBITDA data on file, last reported at $29.1 million in Q1 2026.
- Quarterly EBITDA rose 166.33% year-over-year to $29.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.0 million (up 147.49% YoY) and the FY2025 annual result came in at $20.9 million, up 111.93% from the prior year.
- EBITDA declined to $29.1 million in Q1 2026 per SLNO's latest filing, from $43.4 million in the prior quarter.
- Across five years, EBITDA topped out at $43.4 million in Q4 2025 and bottomed at -$75.6 million in Q3 2024.
- The 5-year median for EBITDA is -$8.3 million (2023), against an average of -$11.1 million.
- The widest annual swing landed in 2024, when EBITDA tumbled 595.71%; it then jumped 176.82% in 2025.
- Tracing SLNO's EBITDA over 5 years: stood at -$5.5 million in 2022, then sank by 105.96% to -$11.3 million in 2023, then sank by 400.36% to -$56.5 million in 2024, then jumped by 176.82% to $43.4 million in 2025, then plunged by 32.91% to $29.1 million in 2026.
- Per Business Quant, the three latest SLNO EBITDA figures stand at $29.1 million (Q1 2026), $43.4 million (Q4 2025), and $26.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -13.63 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.44 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 661.60 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 201.19 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 29.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.13 Mn |
| Dec 31, 2025 | 43.41 Mn |
| Sep 30, 2025 | 26.29 Mn |
| Jun 30, 2025 | -4.85 Mn |
| Mar 31, 2025 | -43.91 Mn |
| Dec 31, 2024 | -56.52 Mn |
| Sep 30, 2024 | -75.57 Mn |
| Jun 30, 2024 | -21.90 Mn |
| Mar 31, 2024 | -21.50 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Sep 30, 2023 | -10.86 Mn |
| Jun 30, 2023 | -8.49 Mn |
| Mar 31, 2023 | -8.34 Mn |
| Dec 31, 2022 | -5.48 Mn |
| Sep 30, 2022 | -6.13 Mn |
| Jun 30, 2022 | -6.72 Mn |
| Mar 31, 2022 | -5.73 Mn |
| Dec 31, 2021 | -3.00 Mn |
| Sep 30, 2021 | -8.14 Mn |
| Jun 30, 2021 | -10.99 Mn |
| Mar 31, 2021 | -8.95 Mn |
| Dec 31, 2020 | -7.96 Mn |
| Sep 30, 2020 | -7.86 Mn |
| Jun 30, 2020 | -11.19 Mn |
| Mar 31, 2020 | -9.28 Mn |
| Dec 31, 2019 | -6.75 Mn |
| Sep 30, 2019 | -6.13 Mn |
| Jun 30, 2019 | -5.62 Mn |
| Mar 31, 2019 | -4.98 Mn |
| Dec 31, 2018 | -3.54 Mn |
| Sep 30, 2018 | -3.88 Mn |
| Jun 30, 2018 | -3.41 Mn |
| Mar 31, 2018 | -3.48 Mn |
| Dec 31, 2017 | -5.20 Mn |
| Sep 30, 2017 | -2.63 Mn |
| Jun 30, 2017 | -2.97 Mn |
| Mar 31, 2017 | -1.37 Mn |
| Dec 31, 2016 | -1.83 Mn |
| Sep 30, 2016 | -1.97 Mn |
| Jun 30, 2016 | -2.30 Mn |
| Mar 31, 2016 | -4.26 Mn |
| Dec 31, 2015 | -3.51 Mn |
| Sep 30, 2015 | -3.18 Mn |
| Jun 30, 2015 | -3.04 Mn |
| Mar 31, 2015 | -2.43 Mn |
| Dec 31, 2014 | -1.85 Mn |
| Sep 30, 2014 | -1.32 Mn |
| Jun 30, 2014 | -1.31 Mn |
| Mar 31, 2014 | -684,000.00 |
| Dec 31, 2013 | -559,783.00 |
| Sep 30, 2013 | -993,000.00 |